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wOur aim, as well as our mission, is to save the
vulnerable patient. We can subdivide the problem
into “vulnerable plaque,” “vulnerable blood,” and
“vulnerable myocardium” (1,2). That still effec-
tive concept of vulnerable myocardium” also in-
cluded the differentiation of myocardial tissue in
nonischemic and ischemic heart disease including
acute injury. The overall idea was to identify the
vulnerable patient before life-threatening ar-
rhythmias, the development of acute events, or
heart failure occurs or worsens. Therefore, a
See page 269
well-defined strategy is needed. Although no one is
expected to find the Holy Grail in the near future, a
strategy is needed that includes clinical aspects and
integrated biomarkers. Imaging offers the chance to
get insight into an injury that meets the overall
expectation of a biomarker (3) and offers the chance to
enhance the ability of a clinician to manage the patient
optimally. That would mean in the case of acute injury
having an effective, robust technique of added value to
visualize the tissue damage before irreversible myocar-
dial changes develop.
Cardiac magnetic resonance (CMR) is able to
image noninvasively and without radiation to the
“vulnerable myocardium,” including differentiating
myocardial injury in ischemic and nonischemic heart
disease by using different techniques with and without
the use of contrast-media enhanced techniques. The
application of T2-weighted imaging has opened the
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to disclose.oor to visualizing myocardial edema. Friedrich (4)
iscussed edema as a generic component of the tissue
esponse to acute injury. Therefore, the technique
ould become an important diagnostic tool for assess-
ng the acuity of tissue damage in vivo and the
otential use of water-sensitive CMR to visualize
lterations in vivo. CMR has an important role in
atients with acute myocardial infarction.
Late gadolinium enhancement (LGE) can detect
nfarct scarring in coronary artery disease (5). This
ethod can identify even small subendocardial lesions
hat are not detectable by single-photon emission
omputed tomography (6). CMR findings were
hown to have prognostic value (7), and CMR can
lso distinguish between acute and chronic changes
fter myocardial infarction (8). Furthermore, the area
t risk was identified by the bright area on T2-
eighted imaging in canine models (9) and verified in
atients (10). The myocardial salvage index, which is
alculated as the area at risk minus the infarct size
ivided by the area at risk, predicts the outcome in
cute myocardial infarction (11). Finally, T2-weighted
maging results augmented other prognostic informa-
ion (12).
The application of combined imaging protocols,
ncluding contrast-enhanced sequences, offers the
nique possibility of differentiating reversible and
rreversible injury not only in ischemic but also in
nflammatory disease (13). That perception led to a
onsensus paper proposing a combined CMR proto-
ol in inflammatory disease (14).
A recent review article summarized the capabilities
f CMR in acute coronary syndrome (15). There is
reliminary evidence from a canine model that T2-
eighted imaging of edema allows the detection of
cute ischemic myocyte injury before LGE is visible
16). The circumstances are such that LGE is already
etectable in the first hour after the onset of ischemia,
hich could be the case even in patients (17). Thus, its
se is all the more attractive. T2-weighted imaging is
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280helpful in terms of decision making in patients with
acute chest pain who present to the emergency de-
partment (18).
A comprehensive view on different stages of myo-
cardial injury is needed without any doubt, but the
imaging-technique itself is sometimes difficult due to
technical limitations. Different T2-weighted tech-
niques are used to provide imaging of edema. In 1996,
a “black blood” T2-weighted inversion recovery tech-
nique was introduced by Simonetti et al. (19), leading
to widespread use. Fast spin echo sequences are often
used, but commonly have several limitations including
dependence on the patient’s condition, as discussed
elsewhere (20,21). Alternative sequences were intro-
duced to offer robust approaches for the detection of
acute myocardial infarction–related edema including
T2-prepared steady-state free precession—(22) and
T2 turbo spin echo steady-state free precession se-
quences (23). Nevertheless, in myocardial disorders
with homogeneous edema, a quantitative approach
would be superior compared with a qualitative one.
Moreover, this approach could overcome coil-related
inhomogeneities. Therefore, quantitative mapping
techniques could offer an alternative to current tech-
niques. In 2009, Giri et al. (24) introduced a quanti-
tative T2 mapping approach. This approach has the
potential to increase the accuracy of the detection of
myocardial edema. In this issue of iJACC, the same
group (25), led by Raman, has provided evidence that
the concept is valid in a clinical setting. They evaluated
quantitative T2 mapping in a 16-segment model and
compared it with conventional T2-weighted imaging
in 27 patients with acute myocardial infarction. The
T2 of the infarct zone was significantly higher com-
pared with the T2 of the remote myocardium in
non–ST-segment elevation myocardial infarction and
ST-segment elevation myocardial infarction. Verhaert
et al. (25) showed that the T2 of remote myocardium113:2335–62. 2003;361:374–9.more, T2 maps yield more robust findings than
conventional short tau inversion recovery (STIR). The
STIR was uninterpretable in 7% (2 patients), and
edema was not detectable in others, mainly those with
NSTEMI. Therefore, the investigators concluded
that quantitative T2 mapping reliably identifies myo-
cardial edema without the limitations encountered by
T2 STIR imaging. Furthermore, the method may be
clinically more robust compared with other methods
in terms of revealing acute ischemic injury. Although
these results are very promising, we are aware that the
number of patients was small and confirmatory data
will be necessary.
CMR can detect myocardial injury, even in the
presence of preserved ejection fraction and absent
fibrotic transformation of the myocardium. Particu-
larly in inflammatory disease, the quantification of a
diffuse myocardial edema is a challenge that could be
assisted by mapping techniques. A quantitative ap-
proach could give us insight into underlying mecha-
nisms, evolving myocardial injury, and early therapeu-
tic intervention. In this regard, Verhaert et al. (25)
have moved us 1 step further.
Although the clinical needs are mainly defined,
further technical development such as 3-
dimensional approaches with a high spatial reso-
lution are warranted but must be proven to meet
the required diagnostic accuracy.
Having techniques such as this, CMR should be
a part of a diagnostic workup and a part of a
multimodality disease-dedicated concept by offer-
ing its unique features.
Reprint requests and correspondence: Prof. Dr. Jeanette
chulz-Menger, Working Group on Cardiovascular
agnetic Resonance, Medical University Berlin, Charité
ampus Buch, HELIOS Klinikum Berlin-Buch,
chwanebecker Chaussee 50, 13125 Berlin, Germany.was not different from that of volunteers. Further- E-mail: jeanette.schulz-menger@charite.de.R E F E R E N C E S
1. Naghavi M, Libby P, Falk E, et al.
From vulnerable plaque to vulnerable
patient: a call for new definitions and
risk assessment strategies: part I. Circu-
lation 2003;108:1664–72.
2. Naghavi M, Libby P, Falk E, et al.
From vulnerable plaque to vulnerable
patient: a call for new definitions and
risk assessment strategies: part II. Cir-
culation 2003;108:1772–8.
3. Vasan RS. Biomarkers of cardiovascu-
lar disease: molecular basis and prac-
tical considerations. Circulation 2006;4. Friedrich MG. Myocardial edema—a
new clinical entity? Nat Rev Cardiol
2010;7:292–6.
5. Kim RJ, Fieno DS, Parrish TB, et al.
Relationship of MRI delayed contrast
enhancement to irreversible injury, in-
farct age, and contractile function.
Circulation 1999;100:1992–2002.
6. Wagner A, Mahrholdt H, Holly TA, et
al. Contrast-enhanced MRI and routine
single photon emission computed to-
mography (SPECT) perfusion imaging
for detection of subendocardial myocar-
dial infarcts: an imaging study. Lancet7. Kwong RY, Chan AK, Brown KA,
et al. Impact of unrecognized myo-
cardial scar detected by cardiac mag-
netic resonance imaging on event-
free survival in patients presenting
with signs or symptoms of coronary
artery disease. Circulation 2006;113:
2733– 43.
8. Abdel-Aty H, Zagrosek A, Schulz-
Menger J, et al. Delayed enhance-
ment and T2-weighted cardiovascu-
lar magnetic resonance imaging
differentiate acute from chronic myo-
cardial infarction. Circulation 2004;
109:2411–6.
11
1
1
1
1
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 3 , 2 0 1 1
M A R C H 2 0 1 1 : 2 7 9 – 8 1
Schulz-Menger
Editorial Comment
2819. Aletras AH, Tilak GS, Natanzon A,
et al. Retrospective determination of
the area at risk for reperfused acute
myocardial infarction with T2-
weighted cardiac magnetic resonance
imaging: histopathological and dis-
placement encoding with stimulated
echoes (DENSE) functional valida-
tions. Circulation 2006;113:1865–70.
10. Friedrich MG, Abdel-Aty H, Taylor
A, Schulz-Menger J, Messroghli D,
Dietz R. The salvaged area at risk in
reperfused acute myocardial infarction
as visualized by cardiovascular mag-
netic resonance. J Am Coll Cardiol
2008;51:1581–7.
11. Eitel I, Desch S, Fuernau G, et al.
Prognostic significance and determi-
nants of myocardial salvage assessed
by cardiovascular magnetic resonance
in acute reperfused myocardial infarc-
tion. J Am Coll Cardiol 2010;55:
2470–9.
12. Raman SV, Simonetti OP, Winner
MW, 3rd, et al. Cardiac magnetic
resonance with edema imaging iden-
tifies myocardium at risk and predicts
worse outcome in patients with non–
ST-segment elevation acute coronary
syndrome. J Am Coll Cardiol 2010;
55:2480–8.
13. Zagrosek A, Abdel-Aty H, Boye P, et
al. Cardiac magnetic resonance mon-
itors reversible and irreversible myo-cardial injury in myocarditis. J Am
Coll Cardiol Img 2009;2:131–8.
4. Friedrich MG, Sechtem U, Schulz-
Menger J, et al. Cardiovascular mag-
netic resonance in myocarditis: a
JACC white paper. J Am Coll Cardiol
2009;53:1475–87.
5. Lockie T, Nagel E, Redwood S, Plein
S. Use of cardiovascular magnetic res-
onance imaging in acute coronary
syndromes. Circulation 2009;119:
1671– 81.
6. Abdel-Aty H, Cocker M, Meek C,
Tyberg JV, Friedrich MG. Edema as a
very early marker for acute myocardial
ischemia: a cardiovascular magnetic
resonance study. J Am Coll Cardiol
2009;53:1194–201.
7. Schulz-Menger J, Gross M, Mess-
roghli D, Uhlich F, Dietz R, Friedrich
MG. Cardiovascular magnetic reso-
nance of acute myocardial infarction at
a very early stage. J Am Coll Cardiol
2003;42:513–8.
8. Cury RC, Shash K, Nagurney JT, et
al. Cardiac magnetic resonance with
T2-weighted imaging improves detec-
tion of patients with acute coronary
syndrome in the emergency depart-
ment. Circulation 2008;118:837–44.
9. Simonetti OP, Finn JP, White RD,
Laub G, Henry DA. “Black blood”
T2-weighted inversion-recovery MR
imaging of the heart. Radiology 1996;
199:49–57.20. Abdel-Aty H, Simonetti O, Friedrich
MG. T2-weighted cardiovascular
magnetic resonance imaging. J Magn
Reson Imaging 2007;26:452–9.
21. Arai AE. Using magnetic resonance
imaging to characterize recent myo-
cardial injury: utility in acute coronary
syndrome and other clinical scenarios.
Circulation 2008;118:795–6.
22. Kellman P, Aletras AH, Mancini C,
McVeigh ER, Arai AE. T2-prepared
SSFP improves diagnostic confidence
in edema imaging in acute myocardial
infarction compared to turbo spin
echo. Magn Reson Med 2007;57:
891–7.
23. Aletras AH, Kellman P, Derbyshire
JA, Arai AE. ACUT2E TSE-SSFP: a
hybrid method for T2-weighted im-
aging of edema in the heart. Magn
Reson Med 2008;59:229–35.
24. Giri S, Chung YC, Merchant A, et al.
T2 quantification for improved detec-
tion of myocardial edema. J Cardio-
vasc Magn Reson 2009;11:56.
25. Verhaert D, Thavendiranathan P,
Giri S, et al. Direct T2 quantification
of myocardial edema in acute ischemic
injury. J Am Coll Cardiol Img 2011;
4:269–78.
Key Words: acute myocardial
infarction y cardiac magnetic
resonance y edema y T2.
